|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Water relationships and incorporation 14C of assimilates in tubers of potato plants differing in potassium nutrition显示文摘 | HELMUT B HANS H MEINOLF L | 1983 | Plant Physiol1983，73，： | 1 |
| 2 | Methods for analysis of citrinin in human blood and urine显示文摘 | Meinolf Blaszkewicz Katherine Mu?oz Gisela H. Degen | 2013 | Archives of Toxicology2013，，6： | 1 |
| 3 | The effect of cellulose-derivatives and emulsifier on creep-recovery and crumb properties of gluten-flee bread prepared from sorghum and gelatinized cassava starch 显示文摘 | Calvin Onyango Gunter Unbehend Meinolf lindhauer | 2009 | Food Research international2009，42，： | 1 |
| 4 | Water relationships and in incorporation C of assimilates in tubers of potato plants differing in potassium nutrition显示文摘 | Helmut B Hans H Meinolf L | 1983 | Plant Physiol1983，，73： | 1 |
| 5 | Effects of Electromagnetic Radiation (Bright Light, Extremely Low- Frequency Magnetic Fields, Infrared Radiation) on the Circa- dian Rhythm of Melatonin Synthesis, Rectal Temperature, and Heart Rate显示文摘 | Griefahn B Kiinemund C Meinolf Blaszkewicz | 2002 | Industrial Health2002，40，： | 1 |
| 6 | First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer显示文摘 | Claus-Henning K?hne Ralf Hofheinz Laurent Mineur Henry Letocha Richard Greil Josef Thaler Eva Fernebro Erick Gamelin Lucy DeCosta Meinolf Karthaus | 2012 | Journal of Cancer Research and Clinical Oncology2012，，1： | 1 |
| 7 | Corporate social reporting in Germany:Conceptual developments and practical experience显示文摘 | Meinolf Dierkes | | 0，，04： | 1 |
| 8 | Yes and PI3K Bind CD95 to Signal Invasion of Glioblastoma显示文摘 | Susanne Kleber Ignacio Sancho-Martinez Benedict Wiestler Alexandra Beisel Christian Gieffers Oliver Hill Meinolf Thiemann Wolf Mueller Jaromir Sykora Andreas Kuhn Nina Schreglmann Elisabeth Letellier Cecilia Zuliani Stefan Klussmann Marcin Teodorczyk Herm | 2008 | Cancer Cell2008，，3： | 1 |
| 9 | Tunneling under Stuttgart Airport Runway显示文摘 | Tegelkamp Meinolf Wittke-Gattermann | 2003 | World Tunnelling2003，16，8： | 1 |
| 10 | Methods for analysis of citrinin in human blood and urine 显示文摘 | Meinolf B Katherine M Gisela H D | 2013 | Archives of Toxicology2013，87，6： | 1 |
| 11 | Effect of reaction conditions and alkyl chain lengths on the properties of hydroxyalkyl starch ethers 显示文摘 | ULRIKE F MEINOLF G L | 2001 | Starch2001，53，11： | 1 |
| 12 | Treatment of invasive fungal infections in cancer patients—Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)显示文摘 | Angelika B?hme Markus Ruhnke Dieter Buchheidt Oliver A. Cornely Herrmann Einsele Ruxandra Enzensberger Holger Hebart Werner Heinz Christian Junghanss Meinolf Karthaus William Krüger Utz Krug Thomas Kubin Olaf Penack Dietmar Reichert Stefan Reuter Gerda Si | 2009 | Annals of Hematology2009，，2： | 1 |
| 13 | Horn of plenty:Value of the international registry for pediatric chronic myeloid leukemia显示文摘Chronic myeloid leukemia(CML)in minors is a rare disease which can be effectively treated by tyrosine kinase inhibitors(TKIs)since the year 2000.A majority of pediatricians will encounter one or two CML patients in the course of their careers and will typically have to rely on written information along with their own intuition to provide care.Knowledge of response to TKIs and of agespecific side effects has an impact on the design of pediatric CML trials in many ways aiming to contribute toward greater predictability of clinical improvements.Information from a registry on a rare disease like CML offers the enormous benefit of enabling treating physicians to interact and share their collective experience.The International Registry on Pediatric CML(IR-PCML)was founded at Poitiers/France almost 10 years ago.Since then,the number of collaboration centers and in parallel of registered patients continuously increased(>550 patients as of December 2019).Ideally,from a given treatment center in a country data are transferred to a national coordinator who interacts with the IR-PCML.In the sense of quality assurance,the registry can offer dissemination of knowledge on state-of-the-art diagnostics(including reference appraisal),optimal treatment approaches,and follow-up procedures within a network that is exerting its strength via participation.With continuous growth during the recent years,very rare subgroups of patients could be identified(e.g.,CML diagnosed at age<3 years,children presenting with specific problems at diagnosis or during course of treatment)which had not been described before.Publications coming from the IR-PCML disseminated this useful information derived from patients who robustly participate and share information about their disease,among themselves and with their caregivers and clinicians.Patient input driving the collection of data on this rare leukemia is the basis for the considerable success of bringing new therapeutics into clinical use. | Meinolf Suttorp Markus Metzler Frédéric Millot | 2020 | World Journal of Clinical Oncology2020，11，6： | 0 |
| 14 | 奈妥匹坦帕洛诺司琼预防化疗引起的恶心呕吐:从临床试验到日常临床实践显示文摘化疗引起的恶心呕吐(CINV)是众多抗癌药物治疗中常见的不良事件,不仅会对患者生活质量带来负面影响,还有可能影响化疗效果。目前,指南建议的止吐方案可以预防大部分癌症患者的CINV。但临床医师并不能始终遵循指南建议,患者也常常难以坚持医师处方的治疗。因此需要采取一些提高指南依从性的方法。奈妥匹坦帕洛诺司琼(NEPA)是首个也是唯一一个固定剂量复方止吐药,由奈妥匹坦(口服)/福奈妥匹坦(静脉给药)与帕洛诺司琼(PALO)组成。NEPA可以联合地塞米松组成三联止吐方案,这是用于高致吐性化疗(HEC)患者和部分中致吐性化疗(MEC)患者预防CINV的推荐方案。因此,NEPA止吐治疗操作简单便捷,可能有助于提高指南依从性。本综述对CINV进行了概括,评价了在临床试验和真实实践中积累的NEPA止吐效果及安全性方面的证据,同时也评价了在关键临床试验之外的环境下,即日常临床环境中使用NEPA进行止吐的初步证据。此外,本文还评述了化疗期间使用NEPA控制恶心症状和提高患者生活质量,这是癌症患者管理中面临的两个大挑战。 | Matti Aapro Karin Jordan Florian Scotté Luigi Celio Meinolf Karthaus Eric Roeland | 2024 | 中国实用医药2024，19，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员